It is time to summon the Black Luster Soldier once again as Kaiyodo debuts their new Yu-Gi-Oh! Duel Monsters Amazing Yamaguchi Revoltech! Coming in at 7.5" tall, this monster is summoned to your ...

The 2025 Yu-Gi-Oh! World Championship is heading to Paris, France, for the first time. In addition to tournaments for Yu-Gi-Oh! trading card game (TCG), the event hosts esports competitions for its ...

Davies seems "determined" to turn the Doctor into a "glorified children's entertainer", costing the show its "ability" to "conjure a chill at tea time". The "smartest thing" that Davies could do ...

A STAR of The Apprentice has become a dad for first time at 50 - after revealing he wants Lord Sugar to be godfather ... in my weaker moments, I say, 'oh, my God, have I left it too late?' ...

The actor, who plays the Fifteenth Doctor on the sci-fi series, is currently airing his second full season as the Time Lord. The broadcaster has now confirmed that Gatwa is being given the big ...

New Zealand are currently the T20 defending champions The Women's T20 World Cup final in 2026 is set to be held at Lord's as the tournament returns to England for the first time since its ...

We hope so. This year’s Lord Mayor’s Hot Air Balloon Regatta is being earmarked to take place on Sunday, May 11. What time does the event start? If the weather holds up, the balloons will take ...

The company also recorded an "impairment loss" of about 26 billion yen (about US$180 million) for the fiscal year ending on ...

How exactly does the titular Your Forma technology work anyway? It's mentioned in this episode it's some kind of thread, ...

Over the years there's been a lot of jaw-dropping dinner party moments, and we've rounded up the biggest arguments of all time, that shocked both the experts and the viewers at home. All good reality ...

Available in a choice of 14 colours, this is a great staple to have in your summer wardrobe. This isn't the first time the Princess of Wales has been spotted wearing Boden. The brand has been one of ...

It’s not the first time that CD47-directed drugs have run into problems with either safety or efficacy. Others that have been abandoned as a result include Surface Oncology’s SRF231 ...